AHLA Healthcare Antitrust FAQ Handbook (Non-Members)
Select a format
In March 2012, the Federal Trade Commission (FTC) ordered two hospitals to unwind the merger that they had previously agreed to, and a month later in April a United States District Court temporarily blocked the merger of two hospitals pending FTC administrative proceedings challenging the merger. These are two recent examples of how antitrust laws can affect business deals in the healthcare industry. Whether you are in-house counsel with a healthcare organization, a healthcare attorney not generally involved with antitrust issues, or even one more familiar with how antitrust issues impact healthcare organizations, you will benefit from this handy guide to what is and isn't allowed in the healthcare antitrust context.
- When is it permissible to talk to a competitor about merging and what information can be shared?
- How do federal antitrust agencies determine when to challenge mergers?
- How can you take advantage of the immunity protection of the Health Care Quality Improvement Act of 1986 (HCQIA) in credentialing matters?
- When are exclusive contracts with primary payers permissible?
- What authority do state attorneys general have to investigate federal antitrust violations?
- In addition, the questions and answers are bolstered by extensive footnotes to aid the reader in further expanding their research into each area of coverage.
Mark L. Mattioli, Esquire
Alexander M. McIntyre, Jr., Esquire, Stephen P. Murphy, Esquire, David M. Narrow, Esquire, Patricia M. Wagner, Esquire, Hillary A. Webber, Esquire
David A. Argue, Ph.D., Saralisa C. Brau, Esquire, Christi J. Braun, Esquire, Joseph M. Miller, Esquire
The eBook versions of this title feature links to Lexis Advance for further legal research options.
Table of Contents
4.9 What About Accountable Care Organizations That Are Established and Operate Under Arrangements with Centers for Medicare & Medicaid Services Under the Medicare Program as Part of the Health Reform Law?
Chapter 5 -- The Robinson-Patman Act
5.1 May a Manufacturer Offer Discounts to Our Competitor Without Offering Us the Same Discounts?
5.1.1 Does the Transaction Involve a Sale of a Commodity?
5.1.2 Are There Two Sales?
5.1.3 Is There a Price Difference in Similar Products?
5.1.4 Did the Sales Occur in Interstate Commerce?
5.1.5 Is There Competitive Injury, and If So, at What Level?
22.214.171.124 Primary Line Injury: Predatory Pricing
126.96.36.199 Secondary Line Discrimination: Lost Profits
188.8.131.52 Tertiary Line Discrimination: Crossing the Border
5.1.6 Defenses to a Robinson-Patman Claim
184.108.40.206 Meeting Competition
220.127.116.11 Cost Justification
18.104.22.168 Changing Conditions
22.214.171.124 Functional Availability
5.2 May a Not-for-Profit Hospital Provide Pharmaceuticals to Its Patients for Use Outside the Hospital Without
Violating the Robinson-Patman Act?
5.3 Can Nonprofit and For-Profit Affiliate Corporations in the Same Health Network Share Products Purchased by the Not-for-Profit Entity Without Violating the Robinson-Patman Act?
Chapter 6 -- Healthcare Payer Issues
6.1 When Are Most Favored Nation Provisions Illegal Under the Antitrust Laws?
6.2 The Dominant Payer Will Not Agree to Our Reasonable Rate Increases. What Can We Do?
6.3 The Local Tertiary Healthcare System Insists on a Significant Rate Increase. Is This an Antitrust Violation?
6.4 Is It Legal for a Hospital System to Offer a Package of Bundled Services to a Payer?
Chapter 7 -- Sharing Healthcare Price and Nonprice Information and Group Purchasing
7.1 Providers Are Asked to Participate in a Pricing Information Survey. Are They Permitted to Participate?
7.2 May Hospitals Share Nonprice Information with Each Other?
7.3 May Wage Surveys Be Used to Assist in Paying Competitive Salaries?
7.4 May a Hospital Enter into Group Purchasing Arrangements?
7.5 Are Local Hospitals Permitted to Collaborate to Develop Clinical Practice Guidelines? What Precautions Do the Hospitals Need to Take?
7.5.1 Standards Must Be Commercial
7.5.2 Conflicts of Interest and Procedural Safeguards
7.5.3 Anticompetitive Harm
Chapter 8 -- Litigation and Enforcement
8.1 Do We Need to Comply with a Third-Party Subpoena or Request from the Government for Detailed Market Information, Including Information in Electronic Form?
8.2 Is There a Statute of Limitations for Antitrust Violations?
8.3 How Are Antitrust Laws Enforced?
8.3.1 Federal Enforcement
8.3.2 State Enforcement
8.3.3 Private Enforcement
8.4 What Authority Do State Attorneys General Have to Investigate Federal Antitrust Violations?
8.5 What Damages Are Available to Plaintiffs in Private Antitrust Lawsuits?
8.6 How Do We Make a Complaint to the Governmental Agencies Regarding a Competitor's Potential Anticompetitive Practice?
8.7 What Type of Antitrust Guidance Is Available from the Government?